These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26039995)

  • 21. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
    Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
    J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.
    Chen KF; Tai WT; Huang JW; Hsu CY; Chen WL; Cheng AL; Chen PJ; Shiau CW
    Eur J Med Chem; 2011 Jul; 46(7):2845-51. PubMed ID: 21531053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathways.
    Chen W; Wu J; Shi H; Wang Z; Zhang G; Cao Y; Jiang C; Ding Y
    Biomed Res Int; 2014; 2014():764981. PubMed ID: 25057499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis.
    Hennenberg M; Trebicka J; Kohistani Z; Stark C; Nischalke HD; Krämer B; Körner C; Klein S; Granzow M; Fischer HP; Heller J; Sauerbruch T
    Lab Invest; 2011 Feb; 91(2):241-51. PubMed ID: 20921950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3.
    Zou Z; Yin Y; Lin J; Hsu LC; Brandon VL; Yang F; Jove R; Jandial R; Li G; Chen MY
    J Neurosurg; 2016 May; 124(5):1310-8. PubMed ID: 26544779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.
    Kong J; Kong F; Gao J; Zhang Q; Dong S; Gu F; Ke S; Pan B; Shen Q; Sun H; Zheng L; Sun W
    Mol Cancer; 2014 Jan; 13():7. PubMed ID: 24418169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginkgetin exhibits antifibrotic effects by inducing hepatic stellate cell apoptosis via STAT1 activation.
    Wang C; Bai Y; Li T; Liu J; Wang Y; Ju S; Yao W; Xiong B
    Phytother Res; 2024 Mar; 38(3):1367-1380. PubMed ID: 38217097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SC-1, a sorafenib derivative, shows anti-tumor effects in osteogenic sarcoma cells.
    Wang CT; Lin CS; Shiau CW; Chu PY; Hsiao CC; Chiang YL; Tai WT; Chen KF
    J Orthop Res; 2013 Feb; 31(2):335-42. PubMed ID: 22926753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways.
    Hao H; Zhang D; Shi J; Wang Y; Chen L; Guo Y; Ma J; Jiang X; Jiang H
    Anticancer Drugs; 2016 Mar; 27(3):192-203. PubMed ID: 26629768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connetive Tissue Growth Factor.
    Seo HY; Lee SH; Lee JH; Kang YN; Hwang JS; Park KG; Kim MK; Jang BK
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways.
    Sommerhalder C; Cummins CB; Wang X; Ramdas D; Lopez ON; Gu Y; Zhou J; Radhakrishnan RS
    J Surg Res; 2021 May; 261():334-342. PubMed ID: 33486415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.
    Lo Re O; Panebianco C; Porto S; Cervi C; Rappa F; Di Biase S; Caraglia M; Pazienza V; Vinciguerra M
    J Cell Physiol; 2018 Feb; 233(2):1202-1212. PubMed ID: 28471474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.
    Tai WT; Cheng AL; Shiau CW; Liu CY; Ko CH; Lin MW; Chen PJ; Chen KF
    Mol Cancer Ther; 2012 Feb; 11(2):452-63. PubMed ID: 22180308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice.
    Choi S; Jung HJ; Kim MW; Kang JH; Shin D; Jang YS; Yoon YS; Oh SH
    Biochem Biophys Res Commun; 2019 May; 513(1):49-55. PubMed ID: 30935693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
    Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.
    Sakurai T; Yada N; Hagiwara S; Arizumi T; Minaga K; Kamata K; Takenaka M; Minami Y; Watanabe T; Nishida N; Kudo M
    Cancer Sci; 2017 Oct; 108(10):1996-2003. PubMed ID: 28777492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGFβ1/Smad3 pathway.
    Cheng Y; Zheng H; Wang B; Xu W; Xu J; Zhu Y
    Dig Liver Dis; 2018 Apr; 50(4):381-388. PubMed ID: 29373239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)-Catechin-7-
    Park YJ; Kim DM; Jeong MH; Yu JS; So HM; Bang IJ; Kim HR; Kwon SH; Kim KH; Chung KH
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation.
    Ding H; Yang X; Tian J; Wang X; Ji Y; El-Ashram S; Ren C; Shen J; Liu M
    Biomed Pharmacother; 2021 Dec; 144():112281. PubMed ID: 34624676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.
    Gu FM; Li QL; Gao Q; Jiang JH; Huang XY; Pan JF; Fan J; Zhou J
    World J Gastroenterol; 2011 Sep; 17(34):3922-32. PubMed ID: 22025881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.